✦ LIBER ✦

A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer

✍ Scribed by Harries, M; Moss, C; Perren, T; Gore, M; Hall, G; Everard, M; A'Hern, R; Gibbens, I; Jenkins, A; Shah, R; Cole, C; Pizzada, O; Kaye, S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of carboplatin followed b

✍ M. FRIEDLANDER; M. BUCK; D. WYLD; M. FINDLAY; B. FITZHARRIS; P. DE SOUZA; T. DAV 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

A phase II study of sequential docetaxel

✍ Eleni M. Karapanagiotou; Adrianni Charpidou; Ifigenia Tzannou; Kalliopi Dilana; 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 159 KB

A phase II study of weekly carboplatin a

✍ Sandro Pignata; Enrico Breda; Giovanni Scambia; Carmela Pisano; Vittorina Zagone 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Gemcitabine–carboplatin–paclitaxel combi

✍ L. FUSO; F. AMANT; P. NEVEN; P. BERTELOOT; I. VERGOTE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

SCOTROC 2B: feasibility of carboplatin f

✍ Clamp, A R; Mäenpää, J; Cruickshank, D; Ledermann, J; Wilkinson, P M; Welch, R; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

A phase II Trial of Weekly Paclitaxel, 5

✍ David M. Loesch; Lina Asmar; Vikki A. Canfield; Gregory A. Parker; Harry E. Hyne 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 99 KB